Table 2 List of PRO measures used (n = 26)
Patient reported outcome title | No. of trials (%) |
|---|---|
EORTC-QLQ-C30 | 10 (39) |
Patient experience questionnaires (various, non-validated) | 6 (23) |
+ Visual analogue scales (various, validated) | 5 (19) |
EORTC-QLQ-LC13 | 3 (12) |
Hospital Anxiety and Depression Scale | 3 (12) |
EQ-5D | 3 (12) |
Economics questionnaires (various, non-validated) | 3 (12) |
EORTC-QLQ-HN35 | 2 (8) |
+ Brief Pain Inventory | 2 (8) |
+ Inflammatory Bowel Disease Questionnaire | 2 (8) |
Medical Research Council Dyspnoea Scale | 2 (8) |
St George’s Respiratory Questionnaire | 2 (8) |
UCLA Prostate Cancer Index | 1 (4) |
Functional Assessment of Cancer Therapy General Questionnaire | 1 (4) |
Xerostomia Questionnaire | 1 (4) |
EORTC-QLQ-CR29 | 1 (4) |
Cleveland Clinic Incontinence Score | 1 (4) |
*Toxicity questionnaire (non-validated) | 1 (4) |
Borg Dyspnoea Scale | 1 (4) |
Lar Scales | 1 (4) |
EORTC-QLQ-PAN26 | 1 (4) |
EORTC-QLQ-CR38 | 1 (4) |
*Numerical Rating Scale | 1 (4) |
Neuropathic Pain Symptom Inventory | 1 (4) |
Short Form-36 | 1 (4) |
Appetite, Hunger and Sensory Perception Questionnaire | 1 (4) |
University of Washington Quality of Life Questionnaire | 1 (4) |
*Measure Yourself Concerns and Wellbeing Questionnaire | 1 (4) |
Leeds Assessment of Neuropathic Symptoms and Signs Pain Score | 1 (4) |
*Palliative care Outcome Scale | 1 (4) |
Dyspnea-12 Scale | 1 (4) |
King’s Brief Interstitial Lung Disease Questionnaire | 1 (4) |
Expanded Prostate Cancer Index Composite | 1 (4) |
Tolerability (non-validated) | 1 (4) |
Body Image Scale | 1 (4) |
*Richards-Campbell Sleep Questionnaire | 1 (4) |
Sleep in the ICU questionnaire (non-validated) | 1 (4) |